ALIMTA Side Effects

7020945-6 | Blood Creatinine Increased, Blood Urea Increased, Creatinine Renal Clearance Decreased, Dehydration, Glomerular Filtration Rate Decreased
on Sep 21, 2010 Male patient from UNITED STATES , 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, creatinine renal clearance decreased, dehydration, glomerular filtration rate decreased. Alimta dosage: 500 Mg/m2, Unk. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

7019171-6 | Abdominal Pain, Clostridium Test Positive, Diverticulum Intestinal, Hyperlipidaemia, Hypertension, Hypokalaemia, Ileus, Malignant Neoplasm Progression, Pleural Effusion
Patient was taking Alimta (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), clostridium test positive, diverticulum intestinal, hyperlipidaemia, hypertension, hypokalaemia, ileus, malignant neoplasm progression, pleural effusion on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 160.5 lb, was diagnosed with non-small cell lung cancer, anxiety (What is anxiety?) and. Alimta dosage: 500 Mg/m2, Other. During the same period patient was treated with BEVACIZUMAB (15 Mg/kg, Other) (View Bevacizumab Review and Bevacizumab Label ), LIPITOR (20 Mg, Daily (1/d)) (View Lipitor Review and Lipitor Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LORAZEPAM (Unk, As Needed) (View Lorazepam Review and Lorazepam Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

7019142-X | Blood Creatinine Increased, Decreased Appetite, Disseminated Intravascular Coagulation, Mucosal Inflammation, Neutropenia, Pyrexia, Sepsis, Thrombocytopenia
Adverse event was reported on Sep 22, 2010 by a Male patient taking Alimta (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma, vitamin supplementation and. Location: ITALY , 72 years of age, After Alimta was administered, patient had the following side effects: blood creatinine increased, decreased appetite, disseminated intravascular coagulation, mucosal inflammation, neutropenia, pyrexia, sepsis (What is sepsis?), thrombocytopenia. During the same period patient was treated with VITAMINS (View Vitamins Review and Vitamins Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

7019140-6 | Anaemia, Gastroenteritis, Gastrointestinal Haemorrhage, Malignant Neoplasm Progression, Oesophagitis, Thrombocytopenia, Toxic Skin Eruption
on Sep 22, 2010 Female patient from SPAIN , 66 years of age, was diagnosed with lung adenocarcinoma and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, gastroenteritis (What is gastroenteritis?), gastrointestinal haemorrhage, malignant neoplasm progression, oesophagitis, thrombocytopenia, toxic skin eruption. Alimta dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.


7015353-8 | Pyrexia
on Sep 21, 2010 Female patient from UNITED STATES , 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta (View Usage). Patient had the following side effects: pyrexia. Alimta dosage: Unk, Unk.

7013671-0 | Leukaemia
Patient was taking Alimta (View Usage). After Alimta was administered, patient had the following side effects: leukaemia on Sep 16, 2010 from BRAZIL Additional patient health information: Female patient , 28 years of age, . Alimta dosage: .

7013666-7 | Anaemia, Oedema
Adverse event was reported on Sep 14, 2010 by a Male patient taking Alimta (View Usage) (Dosage: 500 Mg/m2, Every 3weeks) was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis and. Location: FRANCE , 66 years of age, weighting 253.5 lb, Patient experienced the following unwanted or unexpected effects: anaemia, oedema. During the same period patient was treated with FOLIC ACID W/VITAMIN B12 (View Folic Acid W/vitamin B12 Review and Folic Acid W/vitamin B12 Label ), STEROID ANTIBACTERIALS (View Steroid Antibacterials Review and Steroid Antibacterials Label ), ROXITHROMYCIN (View Roxithromycin Review and Roxithromycin Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), ACEBUTOLOL (400 Mg, Unk) (View Acebutolol Review and Acebutolol Label ), TAHOR (40 Mg, Unk) (View Tahor Review and Tahor Label ), CLOPIDOGREL (1 Tablet Unk, Unk) (View Clopidogrel Review and Clopidogrel Label ), SPIRIVA (View Spiriva Review and Spiriva Label ).

7003294-1 | Bone Pain, Dermatitis, Erythema, Pruritus, Walking Disability
on Sep 10, 2010 Male patient from FRANCE , 53 years of age, weighting 235.9 lb, was diagnosed with lung adenocarcinoma, prophylaxis, vitamin supplementation and was treated with Alimta (View Usage). Patient had the following side effects: bone pain, dermatitis, erythema, pruritus, walking disability. Alimta dosage: . During the same period patient was treated with SOLUPRED (View Solupred Review and Solupred Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ), AVASTIN (7.5 Mg/m2, Unk) (View Avastin Review and Avastin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), PRIMPERAN TAB (From D0 To D4) (View Primperan Tab Review and Primperan Tab Label ), XYZAL (View Xyzal Review and Xyzal Label ).

7003287-4 | Malignant Neoplasm Progression
on Sep 14, 2010 Female patient from UNITED STATES , weighting 102.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: malignant neoplasm progression. Alimta dosage: 500 Mg/m2, Daily (1/d). During the same period patient was treated with ALOXI (50 Ml, Daily (1/d)) (View Aloxi Review and Aloxi Label ), ATIVAN (0.5 Mg, Every 8 Hrs) (View Ativan Review and Ativan Label ), COMPAZINE (10 Mg, As Needed) (View Compazine Review and Compazine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PERCOCET (Unk, As Needed) (View Percocet Review and Percocet Label ), ADVAIR DISKUS 100/50 (Unk, As Needed) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

7002068-5 | Abasia, Neuropathy Peripheral, Walking Aid User, Wheelchair User
Patient was taking Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, neuropathy peripheral, walking aid user, wheelchair user on Sep 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 179.0 lb, was diagnosed with lung neoplasm malignant and. Alimta dosage: 1,000mg. Every 3 Wks. Iv. During the same period patient was treated with CAROPLATIN (600 Mg Every 3 Wks. Iv) (View Caroplatin Review and Caroplatin Label ).

6998083-8 | Chronic Lymphocytic Leukaemia, Dyspnoea, Malignant Neoplasm Progression
Adverse event was reported on Sep 06, 2010 by a Male patient taking Alimta (View Usage) (Dosage: 500 Mg/m2, Other (every 3 Weeks)) was diagnosed with lung adenocarcinoma, vitamin supplementation and. Location: FRANCE , 72 years of age, weighting 165.3 lb, Patient had the following side effects: chronic lymphocytic leukaemia, dyspnoea, malignant neoplasm progression. During the same period patient was treated with CARBOPLATIN (450 Mg, Unk) (View Carboplatin Review and Carboplatin Label ), VITAMIN B 12 (1000 Ug/9 Weeks) (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (0.6 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), LOVENOX (0.6 Ml, Daily (1/d)) (View Lovenox Review and Lovenox Label ), ATACAND (View Atacand Review and Atacand Label ).

6980843-0 | Haemoptysis, Neutrophil Count Decreased
on Sep 08, 2010 Male patient from JAPAN , weighting 108.0 lb, was diagnosed with lung adenocarcinoma stage iv, prophylaxis, cough, pain (What is pain?), insomnia and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: haemoptysis, neutrophil count decreased. Alimta dosage: 750 Mg (500mg/m2), Every 21 Days. During the same period patient was treated with CARBOPLATIN (580 Mg (auc5), Every 21 Days) (View Carboplatin Review and Carboplatin Label ), AVASTIN (750 Mg (15 Mg/kg), Every 21 Days) (View Avastin Review and Avastin Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), METHYCOBAL (View Methycobal Review and Methycobal Label ), MEDICON (30 Mg, 3/d) (View Medicon Review and Medicon Label ), LOXONIN (60 Mg, 3/d) (View Loxonin Review and Loxonin Label ), MUCOSTA (100 Mg, 3/d) (View Mucosta Review and Mucosta Label ), MYSLEE (5 Mg, Daily (1/d)) (View Myslee Review and Myslee Label ).

6980842-9 | Convulsion, Sepsis
on Sep 02, 2010 Male patient from UNITED STATES , weighting 147.0 lb, was diagnosed with malignant peritoneal neoplasm and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, sepsis (What is sepsis?). Alimta dosage: 500 Mg, Unk. During the same period patient was treated with VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6979525-0 | Back Pain, Blood Albumin Decreased, Fatigue, Haemoglobin Decreased, Muscular Weakness, Nausea, Platelet Count Decreased, Pyrexia
Patient was taking Alimta (View Usage). Patient had the following side effects: back pain (What is back pain?), blood albumin decreased, fatigue, haemoglobin decreased, muscular weakness, nausea (What is nausea?), platelet count decreased, pyrexia on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 184.3 lb, was diagnosed with non-small cell lung cancer and. Alimta dosage: 500mg/m2 Q 21 Days 042. During the same period patient was treated with GEMZAR (1250mg/m2 Q 21 Days + Day 8 042) (View Gemzar Review and Gemzar Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), POTASSIUM GLUCONATE TAB (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), ESTER C VITAMIN (View Ester C Vitamin Review and Ester C Vitamin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LASIX (View Lasix Review and Lasix Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6979434-7 | Antineutrophil Cytoplasmic Antibody Increased, Antinuclear Antibody Increased, Cough, Dyspnoea, Haematuria, Haemoptysis, Lung Disorder, Normochromic Normocytic Anaemia
Adverse event was reported on Aug 30, 2010 by a Female patient taking Alimta (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer, lung neoplasm malignant and. Location: UNITED STATES , 54 years of age, After Alimta was administered, patient had the following side effects: antineutrophil cytoplasmic antibody increased, antinuclear antibody increased, cough, dyspnoea, haematuria, haemoptysis, lung disorder, normochromic normocytic anaemia. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6979433-5 | Exfoliative Rash
on Sep 02, 2010 Female patient from JAPAN , 85 years of age, was diagnosed with lung adenocarcinoma, prophylaxis and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: exfoliative rash. Alimta dosage: 500 Mg/m2, Other. During the same period patient was treated with FOLIC ACID (0.5 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (1 Mg, Other) (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6979430-X | Cerebral Infarction, Hemiparesis, Myocardial Infarction
on Sep 01, 2010 Male patient from NETHERLANDS , weighting 240.3 lb, was diagnosed with non-small cell lung cancer stage iv, nausea (What is nausea?) and was treated with Alimta (View Usage). Patient had the following side effects: cerebral infarction, hemiparesis, myocardial infarction. Alimta dosage: . During the same period patient was treated with CISPLATIN (165 Mg, Unk) (View Cisplatin Review and Cisplatin Label ), DEXAMETHASONE TAB (8 Mg, (4 X 2 A 4 Mg) Unk) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), FOLIC ACID (0.5 Mg, Unk (1dd2)) (View Folic Acid Review and Folic Acid Label ), PRIMPERAN TAB (10m, As Needed) (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized and became disabled.

6977443-5 | Lupus-like Syndrome, Photosensitivity Reaction, Rash
Patient was taking Alimta (View Usage). After Alimta was administered, patient had the following side effects: lupus-like syndrome, photosensitivity reaction, rash (What is rash?) on Aug 30, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, was diagnosed with non-small cell lung cancer and. Alimta dosage: 500 Mg/m2, Unk. During the same period patient was treated with VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6971633-3 | Burning Sensation, Pulmonary Embolism
Adverse event was reported on Sep 02, 2010 by a Female patient taking Alimta (View Usage) (Dosage: 500 Mg/m2, Unk) was diagnosed with non-small cell lung cancer, lung neoplasm malignant and. Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: burning sensation, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6970006-7 | Anaemia, Interstitial Lung Disease, Neutropenia, Oral Candidiasis, Thrombocytopenia
on Sep 01, 2010 Male patient from JAPAN , weighting 92.15 lb, was diagnosed with lung adenocarcinoma recurrent, hypertension, dizziness (What is dizziness?), gastritis prophylaxis, prophylaxis of nausea and vomiting, pain (What is pain?), dysgeusia and was treated with Alimta (View Usage). Patient had the following side effects: anaemia, interstitial lung disease, neutropenia, oral candidiasis, thrombocytopenia. Alimta dosage: 650 Mg, Other. During the same period patient was treated with PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), METHYCOBAL (1 Mg, Other) (View Methycobal Review and Methycobal Label ), NORVASC (5 Mg, Daily (1/d)) (View Norvasc Review and Norvasc Label ), DIAZEPAM (2 Mg, 3/d) (View Diazepam Review and Diazepam Label ), TAKEPRON (30 Mg, Daily (1/d)) (View Takepron Review and Takepron Label ), NOVAMIN (5 Mg, 3/d) (View Novamin Review and Novamin Label ), OXYCONTIN (15 Mg, 3/d) (View Oxycontin Review and Oxycontin Label ), GASMOTIN (5 Mg, 3/d) (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized.

6970005-5 | Interstitial Lung Disease
on Sep 02, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: interstitial lung disease. Alimta dosage: Unk, Other. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6969995-6 | Inappropriate Antidiuretic Hormone Secretion, Renal Salt-wasting Syndrome
Patient was taking Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: inappropriate antidiuretic hormone secretion, renal salt-wasting syndrome on Aug 31, 2010 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with lung adenocarcinoma recurrent and. Alimta dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), AVASTIN (View Avastin Review and Avastin Label ).

6969322-4 | Cerebral Infarction, Myocardial Infarction
Adverse event was reported on Aug 25, 2010 by a Male patient taking Alimta (View Usage) (Dosage: ) . Location: NETHERLANDS , 44 years of age, Patient had the following side effects: cerebral infarction, myocardial infarction. Patient was hospitalized.

6969317-0 | Hypoglycaemia, Loss Of Consciousness
on Aug 26, 2010 Female patient from UNITED STATES , 80 years of age, was diagnosed with lung neoplasm malignant and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: hypoglycaemia, loss of consciousness. Alimta dosage: Unk, Unk. Patient was hospitalized.

6969315-7 | Haemoptysis, Neutrophil Count Decreased
on Sep 01, 2010 Male patient from JAPAN , weighting 108.0 lb, was diagnosed with lung adenocarcinoma stage iv, prophylaxis, cough, pain (What is pain?), insomnia and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis, neutrophil count decreased. Alimta dosage: 750 Mg (500mg/m2), Every 21 Days. During the same period patient was treated with CARBOPLATIN (580 Mg (auc5), Every 21 Days) (View Carboplatin Review and Carboplatin Label ), AVASTIN (750 Mg (15 Mg/kg), Every 21 Days) (View Avastin Review and Avastin Label ), PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), MEDICON (30 Mg, 3/d) (View Medicon Review and Medicon Label ), LOXONIN (60 Mg, 3/d) (View Loxonin Review and Loxonin Label ), MUCOSTA (100 Mg, 3/d) (View Mucosta Review and Mucosta Label ), MYSLEE (5 Mg, Daily (1/d)) (View Myslee Review and Myslee Label ).

6969313-3 | Inappropriate Antidiuretic Hormone Secretion
Patient was taking Alimta (View Usage). Patient had the following side effects: inappropriate antidiuretic hormone secretion on Aug 27, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with lung adenocarcinoma and. Alimta dosage: 500 Mg/m2, Unk. During the same period patient was treated with CISPLATIN (75 Mg/m2, Unk) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6969311-X | Vasculitis
Adverse event was reported on Aug 25, 2010 by a Female patient taking Alimta (View Usage) (Dosage: Unk, Unk) was diagnosed with non-small cell lung cancer and. Location: MALAYSIA , 39 years of age, After Alimta was administered, patient had the following side effects: vasculitis (What is vasculitis?). During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6963062-3 | Systemic Inflammatory Response Syndrome
on Aug 23, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with lung neoplasm malignant and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: systemic inflammatory response syndrome. Alimta dosage: 975 Mg, Unk. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BENADRYL (View Benadryl Review and Benadryl Label ). Patient was hospitalized.

6963025-8 | Cough, Decreased Appetite, Haemoptysis, Malignant Neoplasm Progression, Nausea, Rash
on Aug 24, 2010 Male patient from CHINA , 49 years of age, weighting 242.5 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis and was treated with Alimta (View Usage). Patient had the following side effects: cough, decreased appetite, haemoptysis, malignant neoplasm progression, nausea (What is nausea?), rash (What is rash?). Alimta dosage: 500 Mg/m2, Every 21days. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VIT B12 (View Vit B12 Review and Vit B12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6961539-8 | Coma
Patient was taking Alimta (View Usage). After Alimta was administered, patient had the following side effects: coma on Aug 20, 2010 from UNITED STATES Additional patient health information: Male patient , 84 years of age, was diagnosed with non-small cell lung cancer and. Alimta dosage: 350 Mg/m2, Unk. Patient was hospitalized.

6959012-6 | Abdominal Pain, Blood Pressure Increased, Headache, Hyperhidrosis, Malaise, Off Label Use, Serotonin Syndrome, Vomiting
Adverse event was reported on Aug 19, 2010 by a Female patient taking Alimta (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: JAPAN , 57 years of age, weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood pressure increased, headache (What is headache?), hyperhidrosis, malaise, off label use, serotonin syndrome, vomiting. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), IRESSA (View Iressa Review and Iressa Label ), PANVITAN (View Panvitan Review and Panvitan Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), DECADRON (View Decadron Review and Decadron Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6959010-2 | Inappropriate Antidiuretic Hormone Secretion, Renal Salt-wasting Syndrome
on Aug 18, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with lung adenocarcinoma recurrent and was treated with Alimta (View Usage). Patient had the following side effects: inappropriate antidiuretic hormone secretion, renal salt-wasting syndrome. Alimta dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), AVASTIN (View Avastin Review and Avastin Label ).

6946147-7 | Dermatitis Bullous, Rash Erythematous
on Aug 16, 2010 Female patient from BELGIUM , weighting 132.3 lb, was diagnosed with lung neoplasm, antiemetic supportive care and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: dermatitis bullous, rash erythematous. Alimta dosage: 500 Mg/m2, Once. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LITICAN (View Litican Review and Litican Label ), ZOFRAN (View Zofran Review and Zofran Label ), MEDROL (View Medrol Review and Medrol Label ).

6943561-0 | Diarrhoea
Patient was taking Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea on Aug 20, 2010 from PAKISTAN Additional patient health information: Male patient , 50 years of age, weighting 143.3 lb, was diagnosed with lung neoplasm malignant and. Alimta dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ). Patient was hospitalized.

6943560-9 | Pneumatosis Intestinalis
Adverse event was reported on Aug 18, 2010 by a Male patient taking Alimta (View Usage) (Dosage: Unk, Unk) was diagnosed with lung adenocarcinoma stage iv and. Location: JAPAN , 70 years of age, Patient had the following side effects: pneumatosis intestinalis. During the same period patient was treated with PANVITAN (1 G, Daily (1/d)) (View Panvitan Review and Panvitan Label ), METHYCOBAL (1000 Ug, Unk) (View Methycobal Review and Methycobal Label ).

6943559-2 | Intussusception, Pancreatitis Acute
on Aug 16, 2010 Male patient from AUSTRALIA , 62 years of age, was diagnosed with mesothelioma (What is mesothelioma?) and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: intussusception, pancreatitis acute. Alimta dosage: 500 Mg/m2, Every 3 Weeks. During the same period patient was treated with CISPLATIN (500 Mg/m2, Every 3 Weeks) (View Cisplatin Review and Cisplatin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6943557-9 | Abdominal Distension, Blood Sodium Decreased, Chest Discomfort, Epistaxis, Hypophagia, Malignant Neoplasm Progression, Nausea, Neutropenia, Non-small Cell Lung Cancer
on Aug 18, 2010 Male patient from UNITED STATES , weighting 167.2 lb, was diagnosed with non-small cell lung cancer stage 0 and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, blood sodium decreased, chest discomfort, epistaxis, hypophagia, malignant neoplasm progression, nausea (What is nausea?), neutropenia, non-small cell lung cancer. Alimta dosage: 500 Mg/m2, Unk. During the same period patient was treated with AMIODARONE (View Amiodarone Review and Amiodarone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), HEPARIN (View Heparin Review and Heparin Label ), XOPENEX (View Xopenex Review and Xopenex Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

6943554-3 | Pancytopenia, Pneumonia
Patient was taking Alimta (View Usage). Patient had the following side effects: pancytopenia, pneumonia (What is pneumonia?) on Aug 19, 2010 from SWEDEN Additional patient health information: Male patient , 74 years of age, was diagnosed with lung neoplasm malignant and. Alimta dosage: . During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RAMIPRIL HEXAL (View Ramipril Hexal Review and Ramipril Hexal Label ), METOPROLOL SANDOZ (View Metoprolol Sandoz Review and Metoprolol Sandoz Label ), OPTINATE SEPTIMUM (35 Mg, Unk) (View Optinate Septimum Review and Optinate Septimum Label ), LIPITOR (View Lipitor Review and Lipitor Label ), NITROMEX (View Nitromex Review and Nitromex Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6943528-2 | Chronic Obstructive Pulmonary Disease, Condition Aggravated, Hypotension, Oropharyngeal Candidiasis, Pneumonia, Renal Failure, Tachycardia
Adverse event was reported on Aug 25, 2010 by a Male patient taking Alimta (View Usage) (Dosage: 1100 Mg) . Location: UNITED STATES , weighting 211.0 lb, After Alimta was administered, patient had the following side effects: chronic obstructive pulmonary disease, condition aggravated, hypotension, oropharyngeal candidiasis, pneumonia (What is pneumonia?), renal failure, tachycardia. Patient was hospitalized.

6943294-0 | Malignant Neoplasm Progression, Metastases To Spine, Non-small Cell Lung Cancer
on Aug 25, 2010 Male patient from UNITED STATES , weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression, metastases to spine, non-small cell lung cancer. Alimta dosage: 500 Mg/m2 D 1 Q 21 Days Iv. During the same period patient was treated with ABRAXANE (260mg/m2 D 1 Q 21 Days I.v.) (View Abraxane Review and Abraxane Label ).

6941339-5 | Back Pain, Blood Albumin Abnormal, Fatigue, Haemoglobin Abnormal, Muscular Weakness, Nausea, Pyrexia
on Aug 24, 2010 Male patient from UNITED STATES , weighting 184.3 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta (View Usage). Patient had the following side effects: back pain (What is back pain?), blood albumin abnormal, fatigue, haemoglobin abnormal, muscular weakness, nausea (What is nausea?), pyrexia. Alimta dosage: 500mg/m2 Q 21 Days 042. During the same period patient was treated with GEMZAR (1250mg/m2 Q 21 Days + Day 8 042) (View Gemzar Review and Gemzar Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), POTASSIUM GLUCONATE TAB (View Potassium Gluconate Tab Review and Potassium Gluconate Tab Label ), ESTER C VITAMIN (View Ester C Vitamin Review and Ester C Vitamin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LASIX (View Lasix Review and Lasix Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6938095-3 | Abdominal Pain Upper, Asthenia, Back Pain, Blood Creatinine Increased, Diarrhoea, Haematemesis, Metabolic Acidosis, Nausea
Patient was taking Alimta (View Usage). After Alimta was administered, patient had the following side effects: abdominal pain upper, asthenia, back pain (What is back pain?), blood creatinine increased, diarrhoea, haematemesis, metabolic acidosis, nausea (What is nausea?) on Aug 17, 2010 from ITALY Additional patient health information: Male patient , 65 years of age, was diagnosed with lung adenocarcinoma, vitamin supplementation and. Alimta dosage: 900 Mg, Every 21 Days. During the same period patient was treated with CISPLATIN (130 Mg, Every 21 Days) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (1 D/f, As Needed) (View Folic Acid Review and Folic Acid Label ), DOBETIN (View Dobetin Review and Dobetin Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), SOLDESAM (View Soldesam Review and Soldesam Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), KYTRIL (View Kytril Review and Kytril Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6938094-1 | Diarrhoea, Fatigue, Gastritis Erosive, Gastrointestinal Haemorrhage, Malignant Neoplasm Progression, Mouth Ulceration, Mucosal Inflammation, Pancytopenia
Adverse event was reported on Aug 16, 2010 by a Male patient taking Alimta (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer, vitamin supplementation and. Location: UNITED KINGDOM , weighting 216.1 lb, Patient experienced the following unwanted or unexpected effects: diarrhoea, fatigue, gastritis erosive, gastrointestinal haemorrhage, malignant neoplasm progression, mouth ulceration, mucosal inflammation, pancytopenia. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), CISPLATIN (127 Mg, Unk For Cycle 2) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6938093-X | Neoplasm Recurrence, Organising Pneumonia
on Aug 11, 2010 Female patient from FRANCE , 51 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta (View Usage). Patient had the following side effects: neoplasm recurrence, organising pneumonia. Alimta dosage: .

6936913-6 | Anaphylactic Shock
on Aug 09, 2010 Male patient from FRANCE , 60 years of age, was diagnosed with metastases to central nervous system and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: anaphylactic shock. Alimta dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6936909-4 | Mucosal Inflammation
Patient was taking Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: mucosal inflammation on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , 87 years of age, was diagnosed with non-small cell lung cancer and. Alimta dosage: 500 Mg/m2, Unk. During the same period patient was treated with VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FOLIC ACID (1 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), DECADRON (4 Mg, 2/d X 3 Days) (View Decadron Review and Decadron Label ).

6934223-4 | Cough, Decreased Appetite, Haemoptysis, Nausea, Rash
Adverse event was reported on Aug 10, 2010 by a Male patient taking Alimta (View Usage) (Dosage: 500 Mg/m2, Every 21days) was diagnosed with pleural mesothelioma malignant, prophylaxis and. Location: CHINA , 49 years of age, weighting 242.5 lb, Patient had the following side effects: cough, decreased appetite, haemoptysis, nausea (What is nausea?), rash (What is rash?). During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VIT B12 (View Vit B12 Review and Vit B12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6931113-8 | Multi-organ Failure, Off Label Use, Pancytopenia, Toxic Epidermal Necrolysis
on Aug 12, 2010 Female patient from GERMANY , weighting 123.5 lb, was diagnosed with neoplasm malignant and was treated with Alimta (View Usage). After Alimta was administered, patient had the following side effects: multi-organ failure, off label use, pancytopenia, toxic epidermal necrolysis. Alimta dosage: 790 Mg, Daily (1/d). During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ), FOLSAN (View Folsan Review and Folsan Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ).

6928789-8 | Asthenia, Blood Creatinine Increased, Diarrhoea, Nausea, Pancytopenia, Pyrexia
on Aug 11, 2010 Male patient from ITALY , 65 years of age, was diagnosed with lung adenocarcinoma, vitamin supplementation and was treated with Alimta (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood creatinine increased, diarrhoea, nausea (What is nausea?), pancytopenia, pyrexia. Alimta dosage: . During the same period patient was treated with CISPLATIN (130 Mg, Unk) (View Cisplatin Review and Cisplatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DOBETIN (View Dobetin Review and Dobetin Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), SOLDESAM (View Soldesam Review and Soldesam Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), KYTRIL (View Kytril Review and Kytril Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6928787-4 | Colitis Ulcerative, Haemoglobin Decreased, Leukopenia, Platelet Count Decreased
Patient was taking Alimta (View Usage). Patient had the following side effects: colitis ulcerative, haemoglobin decreased, leukopenia, platelet count decreased on Aug 11, 2010 from AUSTRIA Additional patient health information: Female patient , 57 years of age, weighting 238.1 lb, was diagnosed with pleural mesothelioma and. Alimta dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.